Hers vs Ro: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher & Publisher
Hers edges Ro on our rubric, 7.3 to 7.2, a margin narrow enough that we treat it as a tie. The score will not decide this for you. Three concrete differences will: Ro bills insurance and Hers takes none, Ro sells only FDA approved brand name medication while Hers also sells compounded semaglutide and tirzepatide, which are not FDA approved, and on Zepbound specifically Ro is dramatically cheaper.
Disclosure: Hers pays us a commission when you sign up through our links. Ro pays us nothing. Both are scored by the same published methodology, and where Ro is the better buy, this page says so. How we make money.
Hers beats Ro overall, scoring 7.3/10 vs 7.2/10. Ro is more affordable at $149/mo vs $199/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose Ro for users who want fda-approved brand-name glp-1 access includin.
A side-by-side look at Hers and Ro to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#32 of 53The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership, alongside their existing compounded semaglutide and new compounded tirzepatide programs.
Visit HersRo
#40 of 53One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit Ro| Feature | Hers | Ro |
|---|---|---|
| Why each one | The only major women-focused telehealth platform with both a direct Novo Nordisk partnership (Wegovy pen + pill from $149/mo) and a Lilly partnership (Zepbound access) alongside compounded semaglutide and tirzepatide. | The most trusted name in telehealth with the fastest prescription turnaround, same-day approval is standard, not the exception. |
| Our Score | 7.3/10 | 7.2/10 |
| Starting Price | $199/mo | $149/mo |
| Medication Type | Both | Brand |
| Insurance Accepted | No | Yes |
| Best For | Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand | Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing |
| Watch out for | Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings. | Membership and medication are billed separately, readers need to add them together for the all-in monthly cost |
| Ranking | #32 | #40 |
| Get started | Visit Hers | Visit Ro |
Pros & Cons Compared
Hers
Pros
- +2026 Novo Nordisk partnership, FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
- −Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value
Ro
Pros
- +Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149-299/mo via LillyDirect matching
- +Direct insurance billing with major carriers, with coverage, Wegovy or Zepbound can cost $0-25/mo copay
- +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
- +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx, some of the lowest cash brand prices available
Cons
- −Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
- −Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
- −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)
Our Verdict
Hers edges out Ro with a score of 7.3/10 vs 7.2/10. If budget is your priority, Ro is $149/mo, with the medication billed separately compared to Hers from $199/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.
Where Ro wins
Zepbound price, and it is not close. Ro lists Zepbound at $299-449/mo by dose, which lands at $448-598/mo once you add the $149/mo membership. Hers prices brand Zepbound at roughly $1,899/mo cash through its Lilly partnership, and our own Hers review tells readers to treat that price as access rather than value. If Zepbound is the medication you are shopping for, Ro wins this comparison outright.
Insurance. Ro bills major carriers directly, and with coverage brand Wegovy or Zepbound can come down to a $0-25/mo copay. Hers takes no insurance at all; every Hers price is cash.
FDA approval across the whole menu. Ro is brand name only: Wegovy as an injection or an oral pill, Zepbound, and Eli Lilly's Foundayo, an FDA approved oral GLP-1 that launched April 6, 2026. Hers sells compounded semaglutide and compounded tirzepatide alongside its brand options, and compounded medications are not FDA approved. If you want everything you might be prescribed to carry FDA approval, Ro is the more conservative choice.
Third party reviews, narrowly. Ro's Trustpilot sits at 3.9/5 across 5,086 reviews against 3.4/5 across 5,700 for Hers.
Where Hers wins
Compounded options exist at all. Compounded semaglutide is $199/mo all inclusive and compounded tirzepatide runs $199-299/mo. Ro sells neither. The tradeoff is plain and you should not let anyone soften it: compounded GLP-1s cost less and are not FDA approved. Only the brand versions are.
The listed Wegovy cash price. Hers lists the FDA approved Wegovy pen or oral pill at $149/mo through its 2026 Novo Nordisk partnership. Ro's oral Wegovy pill is $149-299/mo by dose plus the $149/mo membership. One caveat we have not closed: we are still re-verifying whether Hers bills a separate membership on top of that $149, so we are not publishing an all-in Hers total yet. Until we do, compare the line items, not the headlines.
Platform breadth for women. Hers folds weight loss into a wider women's health platform that covers hormonal, skin, and wellness care.
What to know before you pick either
Before you pick Hers, two things from our own file. The FDA called Hers' compounded semaglutide marketing “false or misleading”, and complaint site sentiment skews negative on operations: PissedConsumer rates it 1.8/5, with recurring reports of unauthorized charges, hard to cancel subscriptions, and refused refunds. Ro's complaint pattern is different in kind. Reddit users there tend to praise the weight loss results and the drop in food noise, and push back on the separately billed $149/mo membership, cancellation friction, and refund handling. Neither company has a clean file. Decide which complaint you would rather risk living with.
Hers vs Ro: common questions
Is Ro or Hers better for Zepbound?
Ro, decisively. Ro lists Zepbound at $299-449/mo by dose, which is $448-598/mo all in once you add its $149/mo membership. Hers prices brand Zepbound at roughly $1,899/mo cash through its Lilly partnership, and our Hers review reads that as access rather than value. Ro can also bill insurance for Zepbound, and with coverage the copay can run $0-25/mo. Hers takes no insurance.
Is Ro or Hers better for the Wegovy pill?
Both carry the FDA approved oral Wegovy pill, and the honest comparison is unfinished. Hers lists it at $149/mo cash through its 2026 Novo Nordisk partnership. Ro prices it at $149-299/mo by dose plus the $149/mo membership, which is $39 your first month and $74/mo effective on annual prepay, so Ro's ongoing all-in starts around $298/mo before insurance. Ro can bill insurance, though, and with coverage Wegovy can drop to a $0-25/mo copay, which Hers cannot match at any price. The unfinished part: we are re-verifying whether Hers charges a separate membership on top of its $149 figure, so we are not publishing an all-in Hers number yet.
Does Ro or Hers take insurance?
Ro does, Hers does not. Ro bills major carriers directly, and with coverage brand Wegovy or Zepbound can cost $0-25/mo in copay on top of the $149/mo Ro Body membership. At Hers, every price is cash pay.
Is Ro or Hers better for GLP-1 weight loss overall?
Our rubric puts Hers at 7.3 and Ro at 7.2, close enough that we treat it as a tie and so should you. Pick Ro if you want insurance billed directly, Zepbound at a workable cash price, or a menu where every medication is FDA approved brand name, including the new Foundayo oral pill. Pick Hers if you want compounded semaglutide or tirzepatide from $199/mo, which Ro does not offer at all. Know before choosing the compounded route that compounded GLP-1s are not FDA approved, and that the FDA has called Hers' compounded semaglutide marketing “false or misleading”.
Cheapest in our index
Embody
$69/mo flat rate · 7.3/10 · Compounded
Both Hers and Ro start above the cheapest program we track. Across all 53 providers in our index, that floor is Embody at a flat $69/mo, the same rate at every dose, price checked July 31, 2026. It scores 7.3/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
Other matchups readers comparing Hers or Ro tend to look at next.
- Hers vs Sprout Health$199/mo
- Hers vs Enhance MD$212/mo
- Hers vs MEDVi$179/mo
- Ro vs Found$129/mo
- Ro vs GoodRx Care$119/mo
- Ro vs Fella Health$299/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Hers · 7.3/10